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Abstract 
Objectives: To evaluate the ability of BMI, WC and WHtR to identify increased 
cardiometabolic risk in pre-adolescents.  
Methods: This is a cross-sectional study involving 192 children (10.92 ± 0.58 years, 56% 
female) from the United Kingdom between 2010 and 2013. Receiver operating characteristic 
curves determined the discriminatory ability of BMI, WC and WHtR to identify individuals 
with increased cardiometabolic risk (increased clustered triglycerides, HDL-cholesterol, 
systolic blood pressure, cardiorespiratory fitness and glucose).  
Results: A WHtR ≥ 0.5 increased the odds by 5.2 (95% confidence interval 2.6, 10.3) of 
having increased cardiometabolic risk. Similar associations were observed for BMI and WC. 
Both BMI-z and WHtR were fair predictors of increased cardiometabolic risk although BMI-
z demonstrated the best trade-off between sensitivity and specificity, 76.1% and 63.6%, 
compared to 68.1% and 65.5% for WHtR. Cross-validation analysis revealed that BMI-z and 
WHtR correctly classified 84% of individuals (kappa score = 0.671, 95% CI 0.55, 0.79). The 
sensitivity of the cut-points suggests that 89.3% of individuals were correctly classified as 
being at risk with only 10.7% misdiagnosed whereas the specificity of the cut-points 
indicated that 77.8% of individuals were correctly identified as being healthy with 22.2% of 
individuals incorrectly diagnosed as being at risk.  
Conclusions: Findings suggest that WHtR provides similar cardiometabolic risk estimates to 
age and sex adjusted BMI.   
Key Words: Waist-to-height ratio, cardiometabolic risk, youth, screening, adiposity. 
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Introduction 
Body mass index (BMI) is the most commonly used surrogate measure of adiposity in 
children with its use endorsed by numerous international committees and organizations (Cole 
and others, 2000; Cornier and others, 2011; Kavey and others, 2011; World Health 
Organization, 2007). It is an established predictor of a number of adiposity related risk factors 
but despite its widespread use as a simple and inexpensive screening tool, it is not without its 
limitations. By its very definition, BMI cannot distinguish between fat and fat-free mass 
(Khoury and others, 2013) yet obesity is defined as an excess accumulation of body fat with 
excessive abdominal obesity often cited as a key mediator of cardiometabolic dysfunction.  
The measurement of waist circumference (WC) has been used as a simple and inexpensive 
proxy measure to detect the presence of abdominal obesity with some suggesting that WC 
may be a more accurate indicator of cardiometabolic risk in youth (Alberti and others, 2009; 
Savva and others, 2000). Others contend that BMI and WC are comparable indicators 
(Graves and others, 2014). Since both BMI and WC depend on the use of sex and age 
specific percentile charts there is interest in alternative anthropometric indices that may be 
simpler to calculate for practitioners. It has been suggested that a waist-height ratio (WHtR) ≥ 
0.5 is a valid predictor of cardiometabolic risk irrespective of age, sex or ethnicity and may 
be superior than BMI to identify increased cardiometabolic risk in youth (Kahn and others, 
2014; Khoury and others, 2013). Yet findings  are equivocal with some advocating that 
neither WC nor WHtR are superior than BMI as a screening tool for identifying youth with 
increased cardiometabolic risk (Bauer and others, 2015; Freedman and others, 2007).  
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Although variations in methodological approaches and population characteristics may explain 
the contrasting findings, it is evident that few investigations have examined the predictive 
utility of different anthropometric indices to discriminate youth for cardiometabolic risk. 
Moreover, there is a paucity of evidence on the different associations between these 
anthropometric measures and cardiometabolic risk in samples from different settings within 
the UK. Therefore, the aim of this study was to examine the utility of BMI, WC and WHtR as 
screening tools for distinguishing pre-adolescent youth with increased cardiometabolic risk 
profiles.  
Methods: 
Data were derived from the collaborative REACH Year 6 study based in Liverpool and Ulster 
(Boddy and others, 2014) in the summer of 2010 and the baseline data of Scottish children 
recruited for two unpublished intervention studies between 2011 and 2013. The first of these 
studies aimed to examine changes in cardiometabolic risk factors following a 10-week school 
based lifestyle intervention. Ninety-three participants from one school were approached to 
participate in the study resulting in a convenience sample of 44 pre-adolescent schoolchildren 
volunteering to participate. The second of these studies aimed to examine changes in 
cardiometabolic risk factors following an 8-week school based fitness circuit intervention. 
Eighty-two participants from one school were approached to participate in the study, which 
resulted in a convenience sample of 55 pre-adolescent schoolchildren volunteering to 
participate. Only the baseline data of these studies are included in this study.  
In total, 101 healthy participants (n = 45 boys, n = 56 girls), from approximately 300 
participants invited, were recruited for the REACH Year 6 study that examined the 
relationships between cardiometabolic risk, adiposity, cardiorespiratory fitness and 
objectively measured physical activity levels in 9-12-year-old children (Boddy and others, 
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2014). The study was conducted in Liverpool UK and Belfast UK and a convenience sample 
of participants were recruited via primary schools (n= 6 Liverpool Schools, n= 1 Belfast 
school) across both areas. The University of the West of Scotland, Liverpool John Moores 
University and Ulster University ethics committees approved each study. After gaining 
informed consent and participant assent from 200 participants for baseline measures, eight 
were excluded because they were either absent from data collection, withdrew consent or 
identified themselves as being non-fasted. This left 192 children (10.92 ± 0.58 years, ranging 
from 9.5 – 11.9 years, 56% female) as the final sample for this cross-sectional study. 
Measures 
Stature was measured to the nearest 1 mm using a portable stadiometer (Seca Stadiometer, 
Seca Ltd, Birmingham, UK). Body mass was measured to the nearest 0.1 kg using calibrated 
electronic weighing scales (Seca Digital Scales, Seca Ltd, Birmingham, UK).Waist 
circumference was measured at the mid-point between the lower ribs and iliac crest using an 
anthropometric tape as recommended (Ledoux and others, 1997). From measured stature and 
body mass, participants were classified as obese/overweight, or a healthy weight using BMI-z 
scores relative to the UK 1990 BMI population reference data (Cole and others, 1995). Using 
software provided by the Child Growth Foundation (Pan and Cole, 2010) the following 
definitions were applied for healthy weight (BMI z-score <1.04, below the 85th percentile) 
and overweight / obese (BMI z-score ≥1.04, above the 85th percentile) individuals.  Waist 
circumference-z scores were calculated relative to the UK 1988 reference data  (McCarthy 
and others, 2001) using software provided by the Child Growth Foundation (Pan and Cole, 
2010) with a high WC defined as  ≥ the 85th percentile (z-score ≥1.04). WHtR was 
determined by dividing WC by height with values ≥ 0.5 considered high (Bauer and others, 
2015; Graves and others, 2014).  
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Blood pressure (mmHg) was measured once on the participants left arm using automated 
monitors (Omron M10-IT Blood Pressure Monitor HEM-7080IT-E, Omron Healthcare UK 
Ltd, Milton Keynes, UK and a GEDINAMAP ProCare 100–400 Series, UK) after 
participants sat quietly for 10 mins. Cardiorespiratory fitness (CRF) was measured using the 
20m multi stage fitness test (20-MSFT) as described previously (Buchan and others, 2013) or 
through an individually calibrated, continuous incremental treadmill (HP Cosmos, 
Traunstein, Germany) test to volitional exhaustion using breath-by-breath gas analysis 
(Liverpool: Jaeger Oxycon Pro, Viasys Health Care, Warwick, UK, Belfast: COSMED, 
Quark, Italy). Peak VO2 was defined as the highest 15-s average oxygen uptake achieved 
during the test when participants reached volitional exhaustion, and the subjective endpoints 
were met (respiratory exchange ratio>1.05 and/or HR>199 beats/min) or was calculated from 
the 20MSFT score using previously validated equations  (Leger and others, 1988).  
In both of the studies from Scotland, venous samples were obtained from children in a fasted 
state (12 hour fast) by trained phlebotomists. Prior to sampling, participants confirmed that 
they were fasted. Blood samples were taken between 9am - 11am with breakfast provided 
thereafter. Venous samples were collected in a lithium heparin BD Vacutainer Plasma Tube. 
Plasma was isolated through centrifugation at 3500 rpm for 10 minutes, transferred to 
aliquots and stored at – 80° C within 2 hours of collection. Samples were subsequently 
analysed within three months using a RX Monza Clinical Chemistry Analyser (Randox 
Laboratories Limited, Antrim, United Kingdom) for triglyceride (TG), high density 
lipoprotein cholesterol (HDL-C), and glucose. TG content was measured through colorimetry 
and determined through enzymatic hydrolysis (TR 210, Randox, Antrium, UK) with lipases. 
HDL-C was directly measured by precipitating low-density lipoprotein cholesterol (LDL-C) 
and very low-density lipoprotein cholesterol (VLDL-C) through adding phosphotungstic acid 
in the presence of magnesium ions and then centrifuged. Glucose was measured through the 
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glucose oxidase method (GL 364, Randox, Antrium, UK). All physiological and metabolic 
measurements were taken on consecutive days beginning with the metabolic measurements. 
 
Venous samples from the collaborative REACH Year 6 study were collected by paediatric 
phlebotomists between 8.30am and 10.30am on school sites after confirmation of overnight 
fast. Samples were collected using vacutainers (Gold 5ml Clot Activator, Purple 4ml 
K2EDTA, Grey 4ml Sodium Fluoride/Potassium Oxalate) and were then transported to the 
pathology laboratories at Alder Hey Children’s Foundation NHS Trust, or the Ulster Hospital 
for analysis. All analysis assays used in the Reach Year 6 study were standardized between 
the two sites. Samples were measured using the Architect Aeroset System™ for fasting 
plasma glucose [REF 3L82-30], HDL-c [REF 3k33-20] and triglycerides [REF 7D74]. All 
physiological and metabolic measurements were taken on separate days no more than 1 week 
apart.  
Cardiometabolic risk score  
A continuous cardiometabolic risk score was constructed using the following variables: 
Triglycerides, HDL-c (inverted), glucose, systolic BP and cardiorespiratory fitness (VO2peak 
(inverted)). The rationale of including triglycerides, HDL-c (inverted), glucose and systolic 
BP was to calculate a continuous score that is reflective of glucose metabolism, lipid 
metabolism and resting systolic blood pressure. Since these variables are used in the adult 
definition of the metabolic syndrome, our clustered cardiometabolic risk score follows 
previous recommendations which support the inclusion of key metabolic syndrome variables 
within continuous cardiometabolic risk scores (Eisenmann, 2008). The inclusion of 
cardiorespiratory fitness within the continuous cardiometabolic risk score was based on 
findings which suggests that high cardiorespiratory fitness confers significant protection from 
the clustering of cardiometabolic risk factors (Anderssen and others, 2007). Each variable 
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was standardized as follows: standardized value = value-mean/SD, separately for boys and 
girls and by 1 yr. age groups. The z-scores were subsequently summed to construct a 
cardiometabolic risk score for each individual with a lower score being indicative of a 
healthier risk profile.  
Adverse levels of cardiometabolic risk factors 
Reference values from the National Cholesterol Education Program’s (NCEP) Pediatric Panel 
Report (National Cholesterol Education Program, 1992) define a borderline high range for 
triglyceride concentrations as 90-129 mg/dL (1.02-1.46 mmol/L). Thus, 1.24 mmol/L was 
used as the midpoint with values ≥ 1.24 mmol/L considered elevated. For borderline low 
HDL-c the NCEP Pediatric Panel Report propose a range of between 0.91 - 1.16 mmol/L 
regardless of gender or age (National Cholesterol Education Program, 1992). As with 
triglycerides, the midpoint of this range (1.03 mmol/L) was used to define low HDL-c levels.  
Impaired fasting glucose was defined as ≥ 5.6 mmol/L according to the International Diabetes 
Federation recommendation for youth (Zimmet and others, 2007). Elevated Systolic BP was 
defined as ≥ 90th percentile for age, sex and height in accordance with published guidelines 
(National High Blood Pressure Education Program, 2004). Participants were classified as ‘fit’ 
or ‘unfit’ using recommended thresholds (46.6 and 41.9 mL/kg/min for boys and girls, 
respectively) (Boddy and others, 2012).  
Statistical analysis 
Data were checked for normality of distribution and analysed using the Students t-test or the 
Mann Whitney test where appropriate. Categorical variables were compared using the chi-
squared test. Independent associations between the three anthropometric indices (BMI, WC, 
and WHtR) and cardiometabolic risk were examined using separate multivariable logistic 
regression analysis models. Analyses examined the potential effect modifiers of gender and 
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age with effect modification considered present when the interaction term P-value was <0.05. 
Models then controlled for gender and/or age where necessary. The presence or absence of at 
risk levels of the three anthropometric indices (yes/no) was used as the dependant variable 
with the calculated odds ratios (OR) presented with their 95% confidence intervals (CIs).  
Receiver operating characteristics (ROC) curve analyses demonstrated the discriminatory 
ability of the anthropometric indices for predicting increased cardiometabolic risk quantified 
by the area under the curve (AUC). At each value the sensitivity (true-positive rate), 
specificity (true-negative rate) and positive and negative predictive values (PPV and NPV) 
for predicting increased cardiometabolic risk was calculated. The most sensitive cut-off value 
for the detection of increased cardiometabolic risk was obtained from the Youden index with 
greater accuracy reflected in a higher score (Bauer and others, 2015). ROC AUC values of 
≥0.90 were considered excellent, 0.80–0.89 good, 0.70–0.79 fair, and <0.70 poor (Metz, 
1978). Once we identified which adiposity measure was the single best predictor for 
increased cardiometabolic risk, we analysed whether adding more adiposity measures would 
lead to a better prediction of increased cardiometabolic risk. The statistical significance of the 
difference between AUCs was tested using the method by DeLong and colleagues (DeLong 
and others, 1988). The goodness of fit of the models was summarised using the Hosmer-
Lemeshow chi-square statistic with a corresponding P-value <0.05 indicating poor fit. For 
each model, the Akaike and Bayesian information criteria (AIC and BIC) are presented as 
descriptive indicators of the relative quality of competing statistical models with smaller 
AICs and BICs indicating preferred models. 
Finally, cross-validation analysis evaluated the accuracy of the established thresholds to 
classify individuals at increased cardiometabolic risk with the classification agreement, 
sensitivity, specificity and kappa coefficients presented.  Kappa coefficients were interpreted 
as follows: <0 less than chance agreement; 0.01–0.20 slight agreement; 0.21–0.40 fair; 0.41–
10 
 
0.60 moderate; 0.61–0.80 substantial; 0.81–1.00 almost perfect agreement (Cohen, 1960). 
McNemars χ2 statistic was used to determine whether significant differences were present 
between the anthropometrical indices in terms of accuracy in classifying individuals 
according to the presence/absence of increased cardiometabolic risk. AUC’s were compared 
using MedCalc 12.5 (MedCalc software, Mariakerkem Belgium) whereas all other data were 
analysed using IBM SPSS Statistics 22 (IBM, Chicago, IL, USA) with P < 0.05 considered 
statistically significant.   
Results 
As shown in Table 1, the overweight/obese group presented with a significantly higher BMI, 
WHtR, WC, triglycerides, systolic and diastolic blood pressure, but significantly lower 
cardiorespiratory fitness levels than healthy weight individuals. The overweight/obese group 
also presented with a significantly higher cardiometabolic risk score than healthy weight 
individuals.  Analysis indicated that 29% of participants were overweight/obese from their 
BMI; 34% had a high WC and 14% had a high WHtR. For the individual components of the 
continuous cardiometabolic risk score (triglycerides, HDL-cholesterol, cardiorespiratory 
fitness, systolic blood pressure and glucose), 8% had hypertriglyceridemia; 16% had low 
levels of HDL-c; 49% were unfit; 21% had elevated systolic BP and 8% had impaired fasting 
glucose. Supplementary Figure 1 displays the proportion (%) of individuals who presented 
with a clustering of individual cardiometabolic risk factors and revealed that 32% presented 
with no adverse risk factors, 46% presented with one, 13% presented with two and 9% 
presented with three.  
The results of the multivariable logistic regression analysis are presented in Table 2. 
Participants who were classified as overweight/obese according to their BMI were 4.8 
(95%CI 2.3, 10.1, P <0.001) times more likely to be unfit, 1.8 (0.9, 3.4) times more likely to 
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present with 2 risk factors and 3.1 (1.6, 6.3, P <0.001) times more likely to have increased 
cardiometabolic risk. Participants with a high WC were 4.6 (1.5, 8.3, P = 0.06) times more 
likely to have elevated triglycerides, 3.2 (1.4, 7.3, P = 0.07) times more likely to have low 
HDL-c, 3.5 (1.7, 7.3, P <0.001) times more likely to be unfit and 2.1 (0.9, 4.9, P = 0.003) 
times more likely to have increased cardiometabolic risk.  Participants with an elevated 
WHtR were 5.3 (2.6, 14.6, P <0.001) times more likely to be unfit, 2.3 (1.0, 5.5, P = 0.042) 
times more likely to present with 2 cardiometabolic risk factors and 5.2 (2.6, 10.3, P <0.001) 
times more likely to have increased cardiometabolic risk than those of a healthy WHtR.   
The AUCs of the three anthropometric indices for the prediction of cardiometabolic risk are 
provided in Table 3. Both BMI-z and WHtR demonstrated similar discriminatory abilities for 
the prediction of cardiometabolic risk suggested by BMI-z cut-off values ≥0.94 and by WHtR 
cut-off values ≥ 0.43. There was no evidence of poor calibration for any models, with all 
Hosmer-Lemeshow P-values > 0.05. The BMI-z model demonstrated the best fit when 
compared to the other adiposity measures since it presented with the lowest AIC and BIC 
values. BMI-z demonstrated the best trade-off between sensitivity and specificity for 
detecting increased cardiometabolic risk, 76.1% and 63.6% compared to 68.1% and 65.5% 
for WHtR. Using a BMI-z threshold cut-point of ≥1.04, the NPV was high, 82.7%, 
suggesting that the risk of individuals with increased cardiometabolic risk is low for those of 
a healthy weight. Nonetheless, the PPV was low indicating a high proportion of false positive 
findings with only 56.5% of individuals who screened positive having increased 
cardiometabolic risk. For WC-z and WHtR, both the observed PPV and NPV were lower than 
those observed for BMI-z (Table 3).  Comparison between the two models that demonstrated 
the greatest AUC’s, BMI-z and WHtR, revealed no significant differences (P = 0.46). Further 
analysis revealed that adding WHtR to the BMI-z model did not yield a higher AUC 
compared to the model with BMI-z alone (data not shown).    
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Comparisons between the anthropometric indices and their ability to predict the 
presence/absence of increased cardiometabolic risk is shown in Table 4. Only the level of 
agreement between the two models demonstrating the highest AUC (BMI-z and WHtR) for 
the prediction of cardiometabolic risk was examined. Cross-validation analysis revealed that 
BMI-z and WHtR correctly classified 84% of individuals (kappa score = 0.671, 95% CI 0.55, 
0.79). The sensitivity of the cut-points suggests that 89.3% of individuals were correctly 
classified as being at risk with only 10.7% misdiagnosed whereas the specificity of the cut-
points suggests that 77.8% of individuals were correctly identified as being healthy with 
22.2% of individuals incorrectly diagnosed as being at risk. McNemars χ2 test revealed no 
significant differences (P = 0.79) between the percentage of individuals whose risk status was 
correctly predicted by WHtR and BMI-z. 
Discussion 
Findings from this cross-sectional study suggest that the UK 1990 BMI definition of 
overweight and obesity performed well in identifying those with increased cardiometabolic 
risk profiles. Comparisons between healthy weight and overweight/obese individuals 
stratified by BMI revealed significant differences in measures of adiposity, blood pressure, 
triglycerides, cardiorespiratory fitness and cardiometabolic risk which is indicative of the 
well-established link between BMI and health-related disorders (Cornier and others, 2011; 
Kavey and others, 2011). Despite this well-established link, some argue that adiposity 
measures that incorporate visceral adiposity may be more accurate in distinguishing 
individuals at increased cardiometabolic risk since excessive visceral adiposity is a key 
mediator of cardiometabolic dysfunction (Lemieux and others, 2000). Yet, findings form this 
study suggests that neither WC-z nor WHtR affords superior discriminatory ability over 
BMI-z in identifying those at increased cardiometabolic risk. 
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In this study, it was demonstrated that being overweight/obese according to participants BMI 
was associated with a more than threefold-increased odds of having increased 
cardiometabolic risk compared to the healthy weight participants. Strong and significant 
associations with increased cardiometabolic risk were also apparent in those individuals 
presenting with an elevated WC and WHtR. Previous investigations have also shown that 
BMI, WC and WHtR perform similarly when identifying individuals with increased 
cardiometabolic risk scores (Kahn and others, 2014; Sardinha and others, 2016). Our 
observations using UK population reference data extend these findings. Another important 
observation was the predictive ability of both BMI and WC. Despite the external reference 
data proposed for WC and BMI coming from two different UK samples, it is encouraging to 
note that both anthropometrical indices are able to identify those individuals at increased 
cardiometabolic risk.  
Findings from the ROC analysis indicated that the AUC’s for both BMI-z and WHtR did not 
differ demonstrating similar abilities in distinguishing those individuals with increased 
cardiometabolic risk profiles, consistent with the findings of others (Bauer and others, 2015; 
Graves and others, 2014; Sardinha and others, 2016). Although the AUC values were far 
from excellent, they are very similar to recent observations (Sardinha and others, 2016) and 
greater than those noted by Magnussen and colleagues (Magnussen and others, 2010) (AUC 
= 0.65) who used childhood BMI values to diagnose adult metabolic syndrome. The optimal 
cut-off points suggested by the ROC analysis for BMI-z (0.94) is below the 85th percentile for 
BMI (Cole and others, 1995) yet, when examining the UK 1990 BMI population reference 
data the z score for BMI lies just below the 83rd percentile. The optimal cut-off point 
suggested by the ROC analysis for WHtR (0.43) appears to be considerably lower than the 
proposed international cut-off point of 0.5 to identify those at increased cardiometabolic risk. 
Nonetheless, a WHtR of 0.50 has yet to be established as the optimal threshold for all ages 
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and ethnicities.  Future studies that can determine population specific WHtR thresholds for 
accurate identification of a number of cardiometabolic disorders may indicate that a WHtR 
close to 0.43 may be an appropriate cut-off point in this population.   
When comparing the classification agreement between the thresholds for BMI-z and WHtR a 
high level of agreement was noted in addition to a greater sensitivity compared to specificity. 
We believe that these observations are important since the well-established thresholds appear 
to be able to identify a greater number of those with increased cardiometabolic risk (i.e. true 
positives).  Given the stigma of being incorrectly identified as being at risk it could be 
suggested that a higher, and more specific, cut-point is used for identifying individuals with 
increased cardiometabolic risk. There is certainly merit to this suggestion but if the 
consequence is a more focused behaviour and lifestyle intervention being accorded to healthy 
individuals who may be exhibiting some level of risk, our findings support the continued use 
of the well-established thresholds. As long as resources are available, lifestyle interventions 
are likely to benefit healthy individuals as well as those identified as being at risk. 
Overall, our findings are in agreement with others who have demonstrated that BMI-z and 
WHtR have similar associations with cardiometabolic risk in youth and that neither WC-z nor 
WHtR provide superior identification of increased cardiometabolic risk when compared to 
BMI (Freedman and others, 2007; Graves and others, 2014; Kahn and others, 2014; Sardinha 
and others, 2016). Yet, the WHtR is a more simplistic index to apply within both the clinical 
and public setting since its measurement does not require conversion to standardized z-scores 
or percentiles. If the intention is to communicate simple messages about health risk, certainly 
the proposal of ‘Keeping your waist circumference to less than half your height’ may be 
much easier for parents and families to remember and understand.  
15 
 
Nonetheless, a WHtR of 0.50 has yet to be established as the optimal threshold to identify 
increased cardiometabolic risk for all age groups and ethnicities. Future work needs to 
determine whether a lower or higher threshold than 0.5 may be more accurate in identifying 
cardiometabolic risk in different populations. Advocates of the WHtR must also address the 
numerous protocols available for WC measurement if practitioners are to be advised to 
capture this measure as part of routine risk assessments (Kahn and others, 2014). Certainly, 
the standardization of a single protocol would likely enhance the adoption of WC as an 
indicator of cardiometabolic risk, which could then be used as part of the WHtR index.  
Limitations of this study should be considered. This cross-sectional design does not allow us 
to confer causality whilst the lack of objectively measured physical activity and dietary 
habits, which are well-established confounders of a number of indicators measured, are 
acknowledged. Another limitation relates to the different protocols used between studies to 
measure cardiorespiratory fitness. Direct assessments of VO2peak require specialised 
equipment and are time-consuming to participants. In the absence of this specialised 
equipment within Scotland, cardiorespiratory fitness was measured using the 20-m multistage 
fitness test with VO2peak estimated using validated equations (Leger and others, 1988). Whilst 
we accept that the determination of VO2peak isn’t likely to be equal between different 
protocols, the equations used to calculate VO2peak from 20mSRT scores have been widely 
used and are validated for use in this age group of children (Leger and others, 1988).  
Finally, whilst the use of clustered cardiometabolic risk scores is common within paediatric 
research it does have its limitations. The z-score approach is based on the premise that each 
selected variable is equally important in defining cardiometabolic risk, but at present, this has 
yet to be confirmed. Despite this limitation, no published weightings for risk components are 
currently available which is why this method of calculating cardiometabolic risk is commonly 
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used in paediatric research which can also compensate, to an extent, for the day-to-day 
fluctuation in single risk factors.  
 A strength of this study relates to the additional analysis examining the discriminatory ability 
of established UK thresholds. To the best of our knowledge, only one previous study (Graves 
and others, 2014) has examined the associations between BMI and WHtR with 
cardiometabolic risk using UK recommended thresholds. Since previous studies have tended 
to focus on North American cohorts, our findings add to the paucity of evidence examining 
the associations between anthropometric indices and cardiometabolic risk in children living 
in different cultural settings. Finally, the inclusion of CRF within the cardiometabolic risk 
score is an additional strength of this study. Individuals with high fitness typically have 
highly functional cardiorespiratory systems that can attenuate cardiometabolic risk, even in 
the presence of excess adiposity. To the best of our knowledge, this is the first study to 
examine the utility of BMI-z, WC-z and WHtR as screening tools to identify cardiometabolic 
risk that has incorporated CRF. 
In conclusion, we have demonstrated that BMI-z and WHtR have similar discriminatory 
abilities in identifying those at cardiometabolic risk. Yet, despite WHtR being a simple 
calculation that may offer a greater understanding from families and children its use by 
practitioners will be limited until a single standardized waist measurement is proposed and 
widely accepted.  
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Supplementary Figure 1. Proportion of individuals with cardiometabolic risk factors.   
 
The proportion of individuals with adverse levels for the following cardiometabolic risk factors 
(triglycerides, HDL-c, glucose, systolic BP and cardiorespiratory fitness) were examined. Values ≥ 
1.24 mmol/L were considered elevated for triglycerides; values ≤ 1.03 mmol/L were used to define 
low HDL-c levels; Values ≥ 5.6 mmol/L for fasting glucose were considered elevated (Zimmet and 
others, 2007). Elevated Systolic BP was defined as ≥ 90th percentile for age, sex and height in 
accordance with published guidelines (National High Blood Pressure Education Program, 2004). 
Values ≤ 46.6 and 41.9 mL/kg/min for boys and girls were used to identify low cardiorespiratory 
fitness (Boddy and others, 2012). Data are presented as mean proportion with 95% CI. 
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Table 1 – Descriptive characteristics of participants by weight status 
Values presented as mean (SD). BMI = Body mass index; HDL-c = high-density lipoprotein 
cholesterol; CRF = cardiorespiratory fitness. BP = Blood Pressure. ǂ Participants were 
classified as obese/overweight, or a healthy weight using BMI-z scores relative to the UK 
1990 BMI population reference data (Cole and others, 1995). The following definitions were 
applied for healthy weight (BMI z-score <1.04, below the 85th percentile) and overweight / 
obese (BMI z-score ≥1.04, above the 85th percentile) individuals. 
 
 
 
 
 
 Healthy Weight ǂ 
N = 137 (72%) 
Overweight/obese ǂ 
N = 55 (28%) 
P value 
Variable    
Gender % (Girls/Boys) 56/44 58/42 0.73 
Age (years) 10.9 (0.6) 11.0 (0.6) 0.41 
BMI (kg/m2) 16.9 (1.5) 23.0 (2.7) <0.001 
Waist-to-height ratio 0.41 (0.04) 0.48 (0.05) <0.001 
Waist Circumference (cm) 59.6 (5.3) 72.2 (7.8) <0.001 
Systolic BP (mmHg) 110 (13) 113 (14) 0.039 
Diastolic BP (mmHg) 64 (7) 67 (8) 0.037 
Glucose  (mmol/L) 4.9 (0.6) 4.8 (8) 0.98 
Triglycerides (mmol/L) 0.7 (0.3) 0.8 (0.3) 0.021 
HDL-c (mmol/L) 1.6 (0.7) 1.5 (0.6) 0.11 
CRF (ml/kg/min) 46.1 (7.3) 40.4 (6.1) <0.001 
Cardiometabolic risk-z score -0.56 (2.9) 1.05 (2.1) <0.001 
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Table 2. Multivariable adjusted OR (95% CI) for cardiometabolic risk indicators across 3 anthropometric indices 
 Body Mass Index a Waist Circumference b Waist-to-Height Ratio c 
Variable OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value 
Hypertriglyceridemia d 1.2 (0.4, 3.5) 0.81 4.6 (1.5, 8.3) 0.06≠ 1.9 (0.3, 6.4) 0.21 
Low HDL-c e 0.7 (3.0, 1.5) 0.35 3.2 (1.4, 7.3) 0.07 1.6 (0.6, 4.5) 0.35 
Impaired fasting Glucose f 1.1 (0.3, 3.8) 0.83 1.4 (0.5, 4.2) 0.55≠ 0.9 (0.2, 4.3) 0.91 
Elevated systolic BP g 0.7 (0.3, 1.4) 0.32 1.2 (0.6, 2.4) 0.68 0.3 (0.6, 1.2) 0.08 
Low CRF h 4.8 (2.3, 10.1)  <0.001 3.5 (1.7, 7.3)  <0.001 5.3 (2.6, 14.6) <0.001¶ 
1 risk factor i 1.3 (0.5, 3.2) 0.57 1.5 (0.8, 2.8)  0.19ǂ 0.5 (0.1, 2.4)  0.40ǂ 
2 risk factors j 1.8 (0.9, 3.4)  0.09ǂ 1.2 (0.5, 2.8) 0.75 2.3 (1.0, 5.5) 0.042 
Cardiometabolic risk * k 3.1 (1.6, 6.3) <0.001 2.1 (0.9, 4.9) 0.003 5.2 (2.6, 10.3) <0.001  
The presence or absence of at risk levels of the three anthropometric indices (yes/no) was used as the dependant variable with the healthy weight group for 
each anthropometric used as the reference group (OR = 1.0). Calculated odds ratios (OR) are presented with their 95% confidence intervals (CIs). ǂ Model 
was adjusted for age. ≠ Model was adjusted for gender. ¶ Model was adjusted for age and gender. HDL-c = high-density lipoprotein cholesterol; BP = Blood 
Pressure. CRF = cardiorespiratory fitness. * Cardiometabolic risk score (Top tertile vs. rest was used). a Healthy N = 137, overweight/obese N = 55. b Healthy 
N = 125, High N = 66. c Healthy N = 164, High = 28.  
d Healthy BMI-z N = 11, overweight/obese from BMI-z N = 5; Healthy WC-z N = 8, High WC-z N = 11; Healthy WHtR N = 12, High WHtR N = 4. 
e Healthy BMI-z N = 19, overweight/obese from BMI-z N = 11; Healthy WC-z N = 6, High WC-z N = 18; Healthy WHtR N = 24, High WHtR N = 6. 
f Healthy BMI-z N = 11, overweight/obese from BMI-z N = 4; Healthy WC-z N = 1, High WC-z N = 7; Healthy WHtR N = 13, High WHtR N = 2. 
g Healthy BMI-z N = 26, overweight/obese from BMI-z N = 14; Healthy WC-z N = 48, High WC-z N = 15; Healthy WHtR N = 38, High WHtR N = 2. 
h Healthy BMI-z N = 55, overweight/obese from BMI-z N = 41; Healthy WC-z N = 51, High WC-z N = 42; Healthy WHtR N = 73, High WHtR N = 22. 
i Healthy BMI-z N = 57, overweight/obese from BMI-z N = 29; Healthy WC-z N = 51, High WC-z N = 34; Healthy WHtR N = 69, High WHtR N = 16. 
j Healthy BMI-z N = 16, overweight/obese from BMI-z N = 18; Healthy WC-z N = 15, High WC-z N = 19; Healthy WHtR N = 22, High WHtR N = 11. 
k Healthy BMI-z N = 31, overweight/obese from BMI-z N = 25; Healthy WC-z N = 21, High WC-z N = 34; Healthy WHtR N = 43, High WHtR N = 18. 
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Table 3. Results of the ROC analysis to identify optimal BMI-z, WC-z and WHtR cut-offs to predict increased cardiometabolic risk. 
Variable 
 
 
 
Cardiometabolic 
risk* 
 BMI-z Waist Circumference-z Waist-to-Height Ratio 
AUC 
(95% CI) 
0.72 
(0.65, 0.79) 
0.67 
(0.59, 0.73) 
0.71 
(0.63, 0.77) 
PPV (%) 56.5 39.6 45.6 
NPV (%) 82.7 76.5 80.6 
P Value <0.001 <0.001 <0.001 
Sensitivity (%) 76.1 64.6 68.1 
 
Specificity (%) 63.6 55.4 65.5 
Hosmer-Lemeshow P 
value 
0.36 0.93 0.77 
AIC 195.6 213.4 205.6 
BIC 198.7 302.1 216.2 
 Cut-points**  
 
0.94 / 82.7 0.50 / 69 0.43 
The AUC was computed over the entire range of specificity and sensitivity values. Results represent the optimal BMI-z, WC-z and WHtR cut-
points of these continuous measures as identified by the Youden index. *Cardiometabolic risk was calculated from the standardized values (z-
scores calculated separately for gender and by 1 yr. age groups) of the following variables: Triglycerides, HDL-c (inverted), glucose, systolic BP 
and cardiorespiratory fitness (VO2peak (inverted)) with the top tertile vs. rest used to indicate increased risk.  ** Optimal cut-points are 
presented as z-score / percentile for BMI-z and WC-z only to aid interpretations. AUC = Area under the curve. PPV = positive predictive value; 
NPV = Negative predictive value; AIC = Akaike information criteria; BIC = Bayesian information criteria.  
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Table 4 Comparison of classification agreement, sensitivity, specificity and kappa coefficients between selected anthropometric indices for 
identfying individuals at increased cardiometabolic risk.  
 
 Agreement % Kappa   
(95% CI) 
Sensitivity % Specificity % P value for McNemar’s 
χ2 statistic 
 
WHtR vs. BMI-z for cardiometabolic risk*  
84 0.671 
(0.55, 0.79) 
89.3 77.8 0.79 
 
* Established thresholds for BMI-z and WHtR (BMI-z score ≥1.04; WHtR ≥0.5) were used to compare classification agreements.  
 
